18F-enzalutamide

N/A

Report date: 2025/01/15 13:54:21
NME

Base Information

Drug Name18F-enzalutamide
Drug Alias NameN/A
ClassificationRadiation-emitting productsSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Europe Bv
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GroningenAstellas Pharma Europe Bv
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A